Legionella testing is carried out to detect the presence of Legionella bacteria, which can cause Legionnaires’ disease, a type of pneumonia. Legionella testing kits help accurately diagnose the infection as early treatment can prevent serious complications. The global Legionella testing market plays a critical role in ensuring public health by monitoring sources of Legionella bacteria in water systems of large buildings, hospitals and hotels. The global Legionella testing market is estimated to be valued at US$ 1,864.7 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growth of the Legionella testing market is primarily driven by the expanded testing of Legionella bacteria owing to rising incidence of Legionnaires’ disease infections. According to the World Health Organization (WHO), Legionnaires’ disease is one of the major causes of atypical pneumonia worldwide. As a result, government and private organizations are encouraging mandatory Legionella testing of water systems. For instance, in the U.S., the Centers for Disease Control and Prevention (CDC) recommends annual testing of high-risk buildings such as long-term care facilities, hotels and hospitals. Moreover, development of advanced and efficient Legionella testing kits is supporting early identification of infections and diagnosis. This is expected to significantly contribute to the market growth over the forecast period.
Segment Analysis

The global Legionella Testing Market is segmented into testing type, technology, end-use, and geography. Based on testing type, the market is segmented into culture methods and urinary antigen tests. The culture methods segment is further divided into conventional culture methods and rapid culture methods. The culture methods segment dominates the market majorly due to the accuracy and gold standard nature of culture testing for Legionella detection. In terms of technology, the market is divided into direct fluorescent antibody (DFA) staining, enzyme immunoassays (EIAs), PCR assays, and others. Of these, PCR assays hold the largest market share due to the sensitivity and specificity offered by the method. By end-use, the Legionella Testing Market is bifurcated into clinical laboratories, hospitals, and others. Clinical laboratories dominate due to the large volume of tests carried out for Legionella detection in these facilities.

Key Takeaways

The global Legionella Testing Market is expected to witness high growth during the forecast period of 2023 to 2030 owing to rising incidences of Legionnaires' disease worldwide.

Regional analysis: North America dominates the global Legionella Testing Market and is expected to remain the leading regional market over the forecast period. This can be attributed to increasing awareness about Legionella testing, growing geriatric population, and the rising prevalence of Legionnaires' disease in the region.

Key players: Key players operating in the Legionella Testing Market are Boston Scientific Corporation, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Medical, B. Braun Melsungen AG, Medtronic Plc., Novo Nordisk A/S, SERAG-WIESSNER GmbH Co., Smithâ€TMs Medical, Terumo Corporation, Stryker Corporation, and NIPRO Medical Corporation. Growing demand for rapid and accurate Legionella testing is encouraging key players to focus on upgrading their product portfolios and adopt strategic collaborations to strengthen their market position.